scispace - formally typeset
K

Kamal Masaki

Researcher at University of Hawaii at Manoa

Publications -  304
Citations -  24883

Kamal Masaki is an academic researcher from University of Hawaii at Manoa. The author has contributed to research in topics: Dementia & Population. The author has an hindex of 78, co-authored 280 publications receiving 22957 citations. Previous affiliations of Kamal Masaki include Kuakini Medical Center & University of Hawaii.

Papers
More filters
Journal ArticleDOI

Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study

TL;DR: Estrogen therapy alone did not reduce dementia or MCI incidence and increased the risk for both end points combined and use of hormone therapy to prevent dementia or cognitive decline in women 65 years of age or older is not recommended.
Journal ArticleDOI

Midlife blood pressure and dementia: the Honolulu–Asia aging study☆

TL;DR: Elevated levels of blood pressure in middle age can increase the risk for late age dementia in men never treated with anti-hypertensive medication, and these results were consistent for Alzheimer's disease and vascular dementia.
Journal ArticleDOI

Frailty: Emergence and Consequences in Women Aged 65 and Older in the Women's Health Initiative Observational Study

TL;DR: This work defines frailty using simple indicators and investigates the predictive validity of this frailty classification for death, hospitalization, hip fracture, and activity of daily living disability.
Journal ArticleDOI

The Association Between Midlife Blood Pressure Levels and Late-Life Cognitive Function: The Honolulu-Asia Aging Study

TL;DR: Midlife SBP is a significant predictor of reduced cognitive function in later life and early control of SBP levels may reduce the risk for cognitive impairment in old age.
Journal ArticleDOI

FOXO3A genotype is strongly associated with human longevity

TL;DR: Long-lived men presented several additional phenotypes linked to healthy aging, including lower prevalence of cancer and cardiovascular disease, better self-reported health, and high physical and cognitive function, despite significantly older ages than controls, several of these aging phenotypes were associated with FOXO3A genotype.